Peptide blog
Research recaps, safety explainers, and regulation news across the peptide world. Educational only. We sell nothing and give no medical advice.
GLP-1 & Weight LossSexual Wellness
Beyond Ozempic: Meet Retatrutide, the Triple-Agonist Peptide Showing Unprecedented Results Retatrutide targets GLP-1, GIP, and glucagon receptors, producing average weight loss of 30% over 80 weeks in trials. Learn how this triple-agonist peptide outperforms semaglutide and tirzepatide, and what it means for metabolic health. GLP-1 & Weight Loss August 9, 2026 
Not Just Blood Flow: How PT-141 Targets the Brain for Sexual Health PT-141 (Bremelanotide) works on brain receptors to boost sexual desire, unlike blood flow drugs. Learn how this FDA-approved peptide differs and who may benefit. Sexual Wellness August 9, 2026